Ambry
Ambry Genetics, Lightbeam Health Solutions Form Genetic Testing Data Partnership
The collaboration is aimed at helping various organizations to predict patients' increased risk for common cancers and chronic conditions.Â
BRCA2 Variants of Unknown Significance Reclassified Through Functional Data Additions
Researchers reclassified 86 percent of variants initially determined to be VUS, potentially changing surveillance or treatment approaches for patients.
Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project
The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.
The MAGENTA and ProGen trials showed that
Germline Genetic Testing, Counseling Move Remote as Pandemic Limits In-Person Care Capacity
Many companies and counselors see the COVID-19 pandemic as a catalyst for moving germline risk testing into a digital-first healthcare model.